Novartis (NVS) 2026 Earnings Outlook: Risks & Opportunities
Novartis faces a nuanced path in 2026, balancing new therapies with cost discipline. This guide breaks down the key d...
An overview of the major forces behind stock index movements, with guidance on tracking catalysts and assessing risk.
21,624 articlesNovartis faces a nuanced path in 2026, balancing new therapies with cost discipline. This guide breaks down the key d...
SoundHound AI is delivering impressive revenue momentum, but its stock has tumbled. This analysis breaks down the dri...
Two fintech giants, Robinhood and Coinbase, battle for every investor's screen. This guide breaks down strengths, ris...
The AI revolution is just getting started, and a few names stand out as strong, long-term bets. This guide highlights...
Investors are buzzing about SpaceX's ambitious revenue target for 2030 and a bold rival coming from AI. This guide br...
A prominent Canadian investment firm has disclosed a new stake in Boyd Group Services, highlighting growing interest ...
A synthetic covered‑call ETF on MicroStrategy stock continues to pay outs through monthly distributions, yet the stra...
When a company's CFO sells a chunk of shares, investors want to know what it means. This guide explains the implicati...
Cathie Wood goes bargain as Ark trims some bets and adds to three promising names. This piece breaks down the three s...
delek holdings rallied today captured market attention as a mid-cap refiner with jet-fuel exposure and a strategic st...
Insider moves can reveal more than a single trade. This article breaks down the photonics director sells 1,511, expla...
When a top executive sells stock, investors want to know if it signals trouble or simply personal planning. This arti...